{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:52:16Z","timestamp":1791355936065,"version":"4.3.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6825,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1023\/a:1011138825593","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T11:26:45Z","timestamp":1040642805000},"page":"621-625","source":"Crossref","is-referenced-by-count":38,"title":["Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine"],"prefix":"10.1016","volume":"12","author":[{"given":"F.","family":"Di Raimondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Giustolisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cacciola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1023\/A:1011138825593_bb0010","series-title":"Chronic Lymphocytic Leukemia. Scientific Advances and Clinical Developments","first-page":"253","article-title":"Chronic lymphocytic leukemia: Staging and prognostic factor","author":"Cheson","year":"1993"},{"key":"10.1023\/A:1011138825593_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01715117","article-title":"Thymidine kinase A tumor marker with prognostic value for non-Hodgkin\u2019s lymphoma and a broad range of potential clinical applications","volume":"65","author":"Hallek","year":"1992","journal-title":"Ann Hematol"},{"key":"10.1023\/A:1011138825593_bb0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-0609.1987.tb00007.x","article-title":"Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia","volume":"38","author":"Kallander","year":"1987","journal-title":"Eur J Haematol"},{"key":"10.1023\/A:1011138825593_bb0025","doi-asserted-by":"crossref","first-page":"13836","DOI":"10.1016\/S0021-9258(17)36723-6","article-title":"Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells","volume":"269","author":"Hengstschlager","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1023\/A:1011138825593_bb0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/hon.2900090603","article-title":"Comparative study of proliferation-associated parameters in B-cell non-Hodgkin\u2019s lymphoma","volume":"9","author":"Rehn","year":"1991","journal-title":"Hematol Oncol"},{"key":"10.1023\/A:1011138825593_bb0035","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/BF01726414","article-title":"Activity of serum thymidine kinase in non-Hodgkin\u2019s lymphoma Relationship to other prognostic factors","volume":"66","author":"Hallek","year":"1988","journal-title":"Klin Wochen"},{"key":"10.1023\/A:1011138825593_bb0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0609.1989.tb00308.x","article-title":"Primarily asymptomatic low-grade non-Hodgkin\u2019s lymphomas: Prediction of symptom-free survival and total survival","volume":"43","author":"Martinsson","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1023\/A:1011138825593_bb0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/bjc.1983.78","article-title":"The use of serum deoxythymidine kinase as a prognostic marker and in the monitoring of patients with non-Hodgkin\u2019s lymphoma","volume":"47","author":"Gronowitz","year":"1983","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1011138825593_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10428199509064927","article-title":"Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase","volume":"18","author":"Suki","year":"1995","journal-title":"Leuk Lymph"},{"key":"10.1023\/A:1011138825593_bb0055","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/1097-0142(19920315)69:6<1368::AID-CNCR2820690611>3.0.CO;2-R","article-title":"Serum thymidine kinase in monoclonal gammopathies","volume":"69","author":"Luoni","year":"1992","journal-title":"Cancer"},{"key":"10.1023\/A:1011138825593_bb0060","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1002\/1097-0142(19841201)54:11<2450::AID-CNCR2820541123>3.0.CO;2-R","article-title":"Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia","volume":"54","author":"Kallander","year":"1984","journal-title":"Cancer"},{"key":"10.1023\/A:1011138825593_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/10428199609054782","article-title":"Serum \u03b22-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma","volume":"22","author":"Hallek","year":"1996","journal-title":"Leuk Lymph"},{"key":"10.1023\/A:1011138825593_bb0070","first-page":"1732","article-title":"Elevated serum thymidine kinase levels identify a subgroup of high risk of disease progression in early, nonsmouldering chronic lymphocytic leukemia","volume":"93","author":"Hallek","year":"1999","journal-title":"Blood"},{"key":"10.1023\/A:1011138825593_bb0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.2830290307","article-title":"Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the National Cancer Institute Sponsored Working Group","volume":"29","author":"Cheson","year":"1988","journal-title":"Am J Hematol"},{"key":"10.1023\/A:1011138825593_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood.V74.1.19.bloodjournal74119","article-title":"Fludarabine: A new agent with major activity against chronic lymphocytic leukemia","volume":"74","author":"Keating","year":"1989","journal-title":"Blood"},{"key":"10.1023\/A:1011138825593_bb0085","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood.V82.6.1695.1695","article-title":"Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment","volume":"82","author":"O\u2019Brien","year":"1993","journal-title":"Blood"},{"key":"10.1023\/A:1011138825593_bb0090","first-page":"1444","article-title":"A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemia","volume":"9","author":"Robertson","year":"1995","journal-title":"Leukemia"},{"key":"10.1023\/A:1011138825593_bb0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/10428199309145882","article-title":"Phase II clinical trial of fludarabine in chronic lymphocytic leukemia on a weekly lowdose schedule","volume":"10","author":"Kemena","year":"1993","journal-title":"Leuk Lymph"},{"key":"10.1023\/A:1011138825593_bb0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ijc.2910330103","article-title":"Deoxythymidine kinase, a novel serum marker of viral and tumor disease","volume":"33","author":"Gronowitz","year":"1984","journal-title":"Int J Cancer"},{"key":"10.1023\/A:1011138825593_bb0105","series-title":"Practical Statistics for Medical Research","first-page":"213","author":"Altman","year":"1991"},{"key":"10.1023\/A:1011138825593_bb0110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1023\/A:1011138825593_bb0115","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chem Rep"},{"key":"10.1023\/A:1011138825593_bb0120","unstructured":"Keating MJ, Smith TL, Lerner S et al Prediction of prognosis following fludarabine therapy as secondary therapy for chronic lymphocytic leukemia Leuk Lymph (submitted)."}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341954114X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341954114X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/12\/5\/621\/19479205\/12-5-621.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T12:39:45Z","timestamp":1621082385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341954114X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S092375341954114X"],"URL":"https:\/\/doi.org\/10.1023\/a:1011138825593","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}